Status:
COMPLETED
LEVITRA® 20mg Special Drug Use Investigation (Long-term)
Lead Sponsor:
Bayer
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18-64 years
Brief Summary
This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction (ED) who cannot obtain sufficient efficacy by dose 10mg of Lev...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- This investigation targets either the patients of 18 years-old or older and under 65 years-old with organic or mixed erectile dysfunction who cannot obtain sufficient efficacy by dose 10mg of Levitra, and the target patients dose is increased to Levitra 20mg. This investigation will be limited to the patients whose tolerability of Levitra 10mg is judged to be no problem.
Exclusion
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
1221 Patients enrolled
Trial Details
Trial ID
NCT00909233
Start Date
August 1 2007
End Date
December 1 2011
Last Update
December 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Japan